PART I Except as otherwise indicated herein or as the context otherwise requires, references in this annual report on Form 10-K to "MacroGenics," the "company," "we," "us" and "our" refer to MacroGenics, Inc. and its consolidated subsidiaries. MacroGenics , the MacroGenics logo, DART , TRIDENT and the phrases Breakthrough Biologics, Life-Changing Medicines and Developing Breakthrough Biologics, Life-Changing Medicines are our trademarks. The other trademarks, trade names and service marks appear...
Q2 FY2026 — expected 2026-08-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-09 | 2025-12-31 | 0001125345-26-000017 | EDGAR | 72K words |
| 2025-03-20 | 2024-12-31 | 0001125345-25-000042 | EDGAR | — |
| 2024-03-07 | 2023-12-31 | 0001125345-24-000060 | EDGAR | — |
| 2023-03-15 | 2022-12-31 | 0001125345-23-000059 | EDGAR | — |
| 2022-02-24 | 2021-12-31 | 0001125345-22-000013 | EDGAR | — |
| 2021-02-25 | 2020-12-31 | 0001125345-21-000035 | EDGAR | — |
| 2020-02-25 | 2019-12-31 | 0001125345-20-000031 | EDGAR | — |
| 2019-02-26 | 2018-12-31 | 0001125345-19-000046 | EDGAR | — |
| 2018-02-27 | 2017-12-31 | 0001125345-18-000022 | EDGAR | — |
| 2017-02-28 | 2016-12-31 | 0001125345-17-000041 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001125345-25-000108 | EDGAR | 17K words |
| 2025-08-14 | 2025-06-30 | 0001125345-25-000101 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0001125345-25-000053 | EDGAR | — |
| 2024-11-05 | 2024-09-30 | 0001125345-24-000160 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0001125345-24-000148 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001125345-24-000088 | EDGAR | — |
| 2023-11-06 | 2023-09-30 | 0001125345-23-000124 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001125345-23-000108 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001125345-23-000076 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0001125345-22-000104 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0001125345-22-000090 | EDGAR | — |
| 2022-05-03 | 2022-03-31 | 0001125345-22-000047 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-09 | 0001125345-26-000018 | EDGAR | 2K words |
| 2026-03-02 | 0001125345-26-000011 | EDGAR | — |
| 2026-02-24 | 0001125345-26-000009 | EDGAR | — |
| 2025-11-20 | 0001125345-25-000111 | EDGAR | — |
| 2025-11-12 | 0001125345-25-000109 | EDGAR | — |
| 2025-08-14 | 0001125345-25-000100 | EDGAR | — |
| 2025-08-13 | 0001125345-25-000094 | EDGAR | — |
| 2025-06-10 | 0001125345-25-000087 | EDGAR | — |
| 2025-05-22 | 0001125345-25-000075 | EDGAR | — |
| 2025-05-13 | 0001125345-25-000054 | EDGAR | — |
223 total filings indexed. 191 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001125345 |
| Ticker | MGNX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.macrogenics.com |
| Listed | 2013-10-10 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report